Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Recurrent or Progressive Glioblastoma Multiforme
NCT00535379Phase 2Unknown
- Sponsor
- Medical University of Innsbruck
- Start
- Oct 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sunitinib in glioblastoma multiforme (GBM), sponsored by Medical University of Innsbruck. Status: unknown.
02
Drugs
sunitinib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00535379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535379.